These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 26880104)
21. Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. Wagenaar JF; Goris MG; Gasem MH; Isbandrio B; Moalli F; Mantovani A; Boer KR; Hartskeerl RA; Garlanda C; van Gorp EC J Infect; 2009 Jun; 58(6):425-32. PubMed ID: 19443038 [TBL] [Abstract][Full Text] [Related]
22. Sweet and Sour: Impact of Early Glycemic Control on Outcomes in Necrotizing Soft-Tissue Infections. Beauchamp LC; Mostafavifar LG; Evans DC; Gerlach AT Surg Infect (Larchmt); 2019; 20(4):305-310. PubMed ID: 30716012 [No Abstract] [Full Text] [Related]
23. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients. Fan WC; Huang CC; Yang YY; Lin A; Lee KC; Hsieh YC; Fung CP; Hsu HC; Hou MC; Lin HC J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435 [TBL] [Abstract][Full Text] [Related]
24. Predictors of mortality and limb loss in necrotizing soft tissue infections. Schwartz S; Kightlinger E; de Virgilio C; de Virgilio M; Kaji A; Neville A; Bennion R; Saltzman DJ Am Surg; 2013 Oct; 79(10):1102-5. PubMed ID: 24160808 [TBL] [Abstract][Full Text] [Related]
25. Pentraxin-3 Is a Strong Biomarker of Sepsis Severity Identification and Predictor of 90-Day Mortality in Intensive Care Units via Sepsis 3.0 Definitions. Chen H; Li T; Yan S; Liu M; Liu K; Zhang H; Gao M; Xiao X Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679604 [TBL] [Abstract][Full Text] [Related]
26. How biomarkers reflect the prognosis and treatment of necrotising soft tissue infections and the effects of hyperbaric oxygen therapy: the protocol of the prospective cohort PROTREAT study conducted at a tertiary hospital in Copenhagen, Denmark. Polzik P; Johansson PI; Hyldegaard O BMJ Open; 2017 Oct; 7(10):e017805. PubMed ID: 28982834 [TBL] [Abstract][Full Text] [Related]
27. Pentraxin-3 (PTX-3) as a potential biomarker for predicting death in hospitalized patients with COVID-19. Barbosa MXS; da Costa Armstrong A; de Souza CDF; do Carmo RF Virol J; 2024 Sep; 21(1):233. PubMed ID: 39334467 [TBL] [Abstract][Full Text] [Related]
28. [Value of detection of pentraxins 3 value combined with measurement of vascular lung water index in prognosis of patients with sepsis]. Sun R; Wang K; Li F; Yang H; Sun X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):48-53. PubMed ID: 25591437 [TBL] [Abstract][Full Text] [Related]
29. Pentraxin-3 Predicts Short- and Mid-term Mortality in Patients with Sepsis and Septic Shock During Intensive Care Treatment. Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U Clin Lab; 2018 Jun; 64(6):999-1011. PubMed ID: 29945330 [TBL] [Abstract][Full Text] [Related]
30. Soluble ICAM-1 is modulated by hyperbaric oxygen treatment and correlates with disease severity and mortality in patients with necrotizing soft-tissue infection. Hedetoft M; Moser C; Jensen PØ; Vinkel J; Hyldegaard O J Appl Physiol (1985); 2021 Mar; 130(3):729-736. PubMed ID: 33444122 [TBL] [Abstract][Full Text] [Related]
31. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12. Audureau E; Hua C; de Prost N; Hemery F; Decousser JW; Bosc R; Lepeule R; Chosidow O; Sbidian E; Br J Dermatol; 2017 Dec; 177(6):1575-1582. PubMed ID: 28452064 [TBL] [Abstract][Full Text] [Related]
32. Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of sepsis and septic shock. Tian R; Wang X; Pan T; Li R; Wang J; Liu Z; Chen E; Mao E; Tan R; Chen Y; Liu J; Qu H Scand J Immunol; 2019 Dec; 90(6):e12823. PubMed ID: 31489646 [TBL] [Abstract][Full Text] [Related]
33. Resolution of organ dysfunction as a predictor of long-term survival in necrotizing soft tissue infections: Analysis of the AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections trial and a retrospective claims database-linked chart study. Brakenridge SC; Wilfret DA; Maislin G; Andrade KE; Walker V; May AK; Dankner WM; Bulger EM J Trauma Acute Care Surg; 2021 Aug; 91(2):384-392. PubMed ID: 33797490 [TBL] [Abstract][Full Text] [Related]
35. [Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients]. Hao C; Hu Q; Zhu L; Xu H; Zhang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):281-285. PubMed ID: 33834968 [TBL] [Abstract][Full Text] [Related]
36. Pentraxin 3 and C-reactive protein in severe meningococcal disease. Sprong T; Peri G; Neeleman C; Mantovani A; Signorini S; van der Meer JW; van Deuren M Shock; 2009 Jan; 31(1):28-32. PubMed ID: 18650775 [TBL] [Abstract][Full Text] [Related]
37. Factors Associated with Mortality and Amputation Caused by Necrotizing Soft Tissue Infections of the Upper Extremity: A Retrospective Cohort Study. Nawijn F; Verhiel SHWL; Lunn KN; Eberlin KR; Hietbrink F; Chen NC World J Surg; 2020 Mar; 44(3):730-740. PubMed ID: 31664494 [TBL] [Abstract][Full Text] [Related]
38. Predictors of Mortality and Amputation in Patients With Necrotizing Soft Tissue Infections of the Upper Extremity. Crowe CS; Yu JL; Yesantharao P; Keys K; Kennedy SA J Hand Surg Am; 2022 Jul; 47(7):629-638. PubMed ID: 35537969 [TBL] [Abstract][Full Text] [Related]
39. PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study. Vecchié A; Bonaventura A; Meessen J; Novelli D; Minetti S; Elia E; Ferrara D; Ansaldo AM; Scaravilli V; Villa S; Ferla L; Caironi P; Latini R; Carbone F; Montecucco F; J Intern Med; 2021 Feb; 289(2):179-192. PubMed ID: 32686253 [TBL] [Abstract][Full Text] [Related]
40. Development and validation of a necrotizing soft-tissue infection mortality risk calculator using NSQIP. Faraklas I; Stoddard GJ; Neumayer LA; Cochran A J Am Coll Surg; 2013 Jul; 217(1):153-160.e3; discussion 160-1. PubMed ID: 23628224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]